OTC · CIK 0000926617
AWHL Aspira Women's Health Inc.
Insider trading from SEC Form 4. Last filing 10 d ago. Close $0.26 on Oct 9, 2026, +18% from the 52-week low and -59% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
18
with a Form 4 at this company
Price and insider trades, last year
AWHLOct 9, 2026 · close 0.26
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Aspira Women's Health Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | John D Fraser director buy | $7,375 16,389 shares | +3% | - | |
| 38Weak | Jeffrey k cohen director buy | $25k 55,556 shares | +17% | - | |
| 46Moderate | Jack W Schuler owner buy | $500k 1,111,111 shares | +41% | - |
Transactions
The last 65 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | John Strahley Chief Financial Officer | AGrant or award Employee Stock Option (Right to Buy)derivative | +97,417 | $0.00 | $0 | 97,417 | 10 d ago |
| Dec 2, 2025 | John D Fraser director | AGrant or award Stock Option (Right to Buy)derivative | +314,811 | $0.00 | $0 | 314,811 | Dec 4, 2025 |
| Dec 2, 2025 | Cynthia D Hundorfean director | AGrant or award Stock Option (Right to Buy)derivative | +238,085 | $0.00 | $0 | 238,085 | Dec 4, 2025 |
| Dec 2, 2025 | Ellen Beausang director | AGrant or award Stock Option (Right to Buy)derivative | +198,097 | $0.00 | $0 | 198,097 | Dec 3, 2025 |
| Dec 2, 2025 | Jeffrey k cohen director | AGrant or award Stock Option (Right to Buy)derivative | +213,518 | $0.00 | $0 | 213,518 | Dec 3, 2025 |
| Dec 2, 2025 | Winfred Parnell director | AGrant or award Stock Option (Right to Buy)derivative | +185,178 | $0.00 | $0 | 185,178 | Dec 3, 2025 |
| Dec 2, 2025 | Jane Pine Wood director | AGrant or award Stock Option (Right to Buy)derivative | +135,592 | $0.00 | $0 | 135,592 | Dec 3, 2025 |
| Sep 17, 2025 | Jeffrey k cohen director | POpen-market purchase Common Stockindirect: By HealthView Asset Management | +55,556 | $0.45 | $25k | 375,697 | Sep 19, 2025 |
| Sep 17, 2025 | Jack W Schuler owner | POpen-market purchase Common Stockindirect: By Jack W. Schuler Living Trust | +1,111,111 | $0.45 | $500k | 3,823,829 | Sep 19, 2025 |
| Sep 17, 2025 | John D Fraser director | POpen-market purchase Common Stock | +16,389 | $0.45 | $7,375 | 566,393 | Sep 19, 2025 |
| Sep 17, 2025 | Jeffrey k cohen director | POpen-market purchase Warrant (Right to Buy)derivative | +41,667 | $0.00 | $0 | 491,985 | Sep 19, 2025 |
| Sep 17, 2025 | John D Fraser director | POpen-market purchase Warrant (Right to Buy)derivative | +12,292 | $0.00 | $0 | 981,549 | Sep 19, 2025 |
| Sep 17, 2025 | Jack W Schuler owner | POpen-market purchase Warrant (Right to Buy)derivativeindirect: By Jack W. Schuler Living Trust | +833,333 | $0.00 | $0 | 833,333 | Sep 19, 2025 |
| Sep 2, 2025 | Brian Hungerford Chief Financial Officer | AGrant or award Employee Stock Option (Right to Buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Sep 4, 2025 |
| Jun 4, 2025 | Ellen O'Connor Vos director | MOption exercise Common Stock | +5,312 | $0.00 | $0 | 73,989 | Jun 6, 2025 |
| Jun 4, 2025 | John Phillip Ragard director | MOption exercise Common Stock | +4,844 | $0.00 | $0 | 134,734 | Jun 6, 2025 |
| Jun 4, 2025 | Ellen O'Connor Vos director | MOption exercise Restricted Stock Unitsderivative | -5,312 | $0.00 | $0 | 0 | Jun 6, 2025 |
| Jun 4, 2025 | John Phillip Ragard director | MOption exercise Restricted Stock Unitsderivative | -4,844 | $0.00 | $0 | 0 | Jun 6, 2025 |
| Jun 4, 2025 | Stefanie L. Cavanaugh director | MOption exercise Common Stock | +5,937 | $0.00 | $0 | 78,726 | Jun 5, 2025 |
| Jun 4, 2025 | Jannie Prestridge Herchuk director | MOption exercise Common Stock | +8,437 | $0.00 | $0 | 82,502 | Jun 5, 2025 |
| Jun 4, 2025 | Winfred Parnell director | MOption exercise Common Stock | +5,156 | $0.00 | $0 | 71,209 | Jun 5, 2025 |
| Jun 4, 2025 | Ellen Beausang director | MOption exercise Common Stock | +4,843 | $0.00 | $0 | 6,458 | Jun 5, 2025 |
| Jun 4, 2025 | Stefanie L. Cavanaugh director | MOption exercise Restricted Stock Unitsderivative | -5,937 | $0.00 | $0 | 0 | Jun 5, 2025 |
| Jun 4, 2025 | Winfred Parnell director | MOption exercise Restricted Stock Unitsderivative | -5,156 | $0.00 | $0 | 0 | Jun 5, 2025 |
| Jun 4, 2025 | Ellen Beausang director | MOption exercise Restricted Stock Unitsderivative | -4,843 | $0.00 | $0 | 0 | Jun 5, 2025 |
| Jun 4, 2025 | Jannie Prestridge Herchuk director | MOption exercise Restricted Stock Unitsderivative | -8,437 | $0.00 | $0 | 0 | Jun 5, 2025 |
| May 9, 2025 | Jeffrey k cohen director | AGrant or award Common Stockindirect: By spouse | +44,260 | $0.07 | $3,098 | 49,260 | Jun 4, 2025 |
| May 13, 2025 | Jeffrey k cohen director | AGrant or award Common Stockindirect: By spouse | +11,653 | $0.07 | $816 | 60,913 | Jun 4, 2025 |
| May 22, 2025 | Michael William Buhle Chief Executive Officer | AGrant or award Stock Options (Right to Buy)derivative | +100,000 | $0.00 | $0 | 100,000 | May 27, 2025 |
| Mar 31, 2025 | Ellen O'Connor Vos director | MOption exercise Common Stock | +5,313 | $0.00 | $0 | 68,677 | Apr 2, 2025 |
| Mar 31, 2025 | Ellen O'Connor Vos director | MOption exercise Restricted Stock Unitsderivative | -5,313 | $0.00 | $0 | 5,312 | Apr 2, 2025 |
| Mar 31, 2025 | John Phillip Ragard director | MOption exercise Common Stock | +4,843 | $0.00 | $0 | 129,890 | Apr 1, 2025 |
| Mar 31, 2025 | Winfred Parnell director | MOption exercise Common Stock | +5,156 | $0.00 | $0 | 66,053 | Apr 1, 2025 |
| Mar 31, 2025 | Ellen Beausang director | MOption exercise Common Stock | +1,615 | $0.00 | $0 | 1,615 | Apr 1, 2025 |
| Mar 31, 2025 | Jannie Prestridge Herchuk director | MOption exercise Common Stock | +8,438 | $0.00 | $0 | 74,065 | Apr 1, 2025 |
| Mar 31, 2025 | Celeste Rachelle Fralick director | MOption exercise Common Stock | +5,000 | $0.00 | $0 | 55,665 | Apr 1, 2025 |
| Mar 31, 2025 | Stefanie L. Cavanaugh director | MOption exercise Common Stock | +5,938 | $0.00 | $0 | 72,789 | Apr 1, 2025 |
| Mar 11, 2025 | Ellen Beausang director | AGrant or award Restricted Stock Unitsderivative | -6,458 | $0.00 | $0 | 6,458 | Apr 1, 2025 |
| Mar 31, 2025 | Winfred Parnell director | MOption exercise Restricted Stock Unitsderivative | -5,156 | $0.00 | $0 | 5,156 | Apr 1, 2025 |
| Mar 31, 2025 | Stefanie L. Cavanaugh director | MOption exercise Restricted Stock Unitsderivative | -5,938 | $0.00 | $0 | 5,937 | Apr 1, 2025 |
| Mar 31, 2025 | Jannie Prestridge Herchuk director | MOption exercise Restricted Stock Unitsderivative | -8,438 | $0.00 | $0 | 8,437 | Apr 1, 2025 |
| Mar 31, 2025 | Celeste Rachelle Fralick director | MOption exercise Restricted Stock Unitsderivative | -5,000 | $0.00 | $0 | 5,000 | Apr 1, 2025 |
| Mar 31, 2025 | John Phillip Ragard director | MOption exercise Restricted Stock Unitsderivative | -4,843 | $0.00 | $0 | 4,844 | Apr 1, 2025 |
| Mar 31, 2025 | Ellen Beausang director | MOption exercise Restricted Stock Unitsderivative | -1,615 | $0.00 | $0 | 4,843 | Apr 1, 2025 |
| Mar 6, 2025 | Jack W Schuler owner | POpen-market purchase Senior Secured Convertible Note due 2030derivativeindirect: By Jack W. Schuler Living Trust | - | $200,000.00 | - | - | Mar 10, 2025 |
| Dec 31, 2024 | Ellen O'Connor Vos director | MOption exercise Common Stock | +5,312 | $0.00 | $0 | 63,364 | Jan 8, 2025 |
| Dec 31, 2024 | Stefanie L. Cavanaugh director | MOption exercise Common Stock | +5,937 | $0.00 | $0 | 66,851 | Jan 8, 2025 |
| Dec 31, 2024 | John Phillip Ragard director | MOption exercise Common Stock | +4,844 | $0.00 | $0 | 125,047 | Jan 8, 2025 |
| Dec 31, 2024 | Sandra Milligan Interim CEO & President | MOption exercise Common Stock | +20,000 | $0.00 | $0 | 20,000 | Jan 8, 2025 |
| Dec 31, 2024 | Celeste Rachelle Fralick director | MOption exercise Common Stock | +5,000 | $0.00 | $0 | 50,665 | Jan 8, 2025 |
| Dec 31, 2024 | Jannie Prestridge Herchuk director | MOption exercise Common Stock | +8,437 | $0.00 | $0 | 65,627 | Jan 8, 2025 |
| Dec 31, 2024 | Winfred Parnell director | MOption exercise Common Stock | +5,157 | $0.00 | $0 | 60,897 | Jan 8, 2025 |
| Dec 31, 2024 | Celeste Rachelle Fralick director | MOption exercise Restricted Stock Unitsderivative | -5,000 | $0.00 | $0 | 10,000 | Jan 8, 2025 |
| Dec 31, 2024 | John Phillip Ragard director | MOption exercise Restricted Stock Unitsderivative | -4,844 | $0.00 | $0 | 9,687 | Jan 8, 2025 |
| Dec 31, 2024 | Winfred Parnell director | MOption exercise Restricted Stock Unitsderivative | -5,157 | $0.00 | $0 | 10,312 | Jan 8, 2025 |
| Dec 31, 2024 | Jannie Prestridge Herchuk director | MOption exercise Restricted Stock Unitsderivative | -8,437 | $0.00 | $0 | 16,875 | Jan 8, 2025 |
| Dec 31, 2024 | Sandra Milligan Interim CEO & President | MOption exercise Restricted Stock Unitsderivative | -20,000 | $0.00 | $0 | 0 | Jan 8, 2025 |
| Dec 31, 2024 | Stefanie L. Cavanaugh director | MOption exercise Restricted Stock Unitsderivative | -5,937 | $0.00 | $0 | 11,875 | Jan 8, 2025 |
| Dec 31, 2024 | Ellen O'Connor Vos director | MOption exercise Restricted Stock Unitsderivative | -5,312 | $0.00 | $0 | 10,625 | Jan 8, 2025 |
| Sep 30, 2024 | John Phillip Ragard director | MOption exercise Common Stock | +4,844 | $0.00 | $0 | 120,203 | Nov 22, 2024 |
| Sep 30, 2024 | John Phillip Ragard director | MOption exercise Restricted Stock Unitsderivative | -4,844 | $0.00 | $0 | 14,531 | Nov 22, 2024 |
| Nov 12, 2024 | John A Kallassy Interim CFO | AGrant or award Stock Options (Right to buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Nov 14, 2024 |
| Nov 12, 2024 | Sandra Milligan President | AGrant or award Stock option (right to buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Nov 13, 2024 |
| Oct 28, 2024 | Nicole Sandford Chief Executive Officer | AGrant or award Restricted Stock Unitsderivative | +25,000 | $0.00 | $0 | 25,000 | Oct 28, 2024 |
| Oct 28, 2024 | Sandra Milligan President | AGrant or award Restricted Stock Unitsderivative | +20,000 | $0.00 | $0 | 20,000 | Oct 28, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Ellen Beausangdirector
- Michael William BuhleChief Executive Officer
- Stefanie L. Cavanaughdirector
- Celeste Rachelle Fralickdirector
- John D Fraserdirector
- Jannie Prestridge Herchukdirector
- Cynthia D Hundorfeandirector
- Brian HungerfordChief Financial Officer
- John A KallassyInterim CFO
- Sandra MilliganInterim CEO & President
- Winfred Parnelldirector
- John Phillip Ragarddirector
- Jack W Schulerdirector, owner, other
- Nicole SandfordChief Executive Officer
- John StrahleyChief Financial Officer
- Ellen O'Connor Vosdirector
- Jane Pine Wooddirector
- Jeffrey k cohendirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.